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mmol L−1) or whole body lipid oxidation during exer-
cise (WHEY 0.37 ± 0.26, GEL 0.36 ± 0.24, PLACEBO 
0.34 ± 0.24 g/min) were apparent between trials, despite 
elevated (P = 0.001) insulin in WHEY and GEL compared 
with PLACEBO (38 ± 16, 35 ± 16, 22 ± 11 pmol L−1, 
respectively). We conclude that leucine-enriched protein 
feeding does not impair FFA availability or whole body 
lipid oxidation during exercise, thus having practical 
applications for athletes who deliberately train in CHO-
restricted states to promote skeletal muscle adaptations.
Keywords Mitochondria · Endurance training · 
Lipolysis · whey
Introduction
Traditional nutritional approaches for endurance training 
have typically promoted high CHO availability before, 
during and after training sessions in order to ensure high 
daily training intensities and volumes as well as promot-
ing recovery (Cermak and Van Loon 2013; Hawley et al. 
1997). However, during the last decade, we and oth-
ers have consistently observed a potent effect of reduced 
CHO availability (i.e. fasted and/or glycogen-depleted 
training) in modulating training-induced adaptations in 
skeletal muscle (Hawley and Morton 2014). For example, 
reducing endogenous and/or exogenous CHO availabil-
ity during short-term (e.g. 3–10 week) endurance training 
increases mitochondrial enzyme activity and protein con-
tent (Morton et al. 2009; Yeo et al. 2008; Van Proeyen 
et al. 2011), increases both whole body (Yeo et al. 2008) 
and intramuscular lipid oxidation (Hulston et al. 2010) 
and in some instances improves exercise capacity (Hansen 
et al. 2005). These data have therefore led to the innovative 
Abstract Given that the enhanced oxidative adaptations 
observed when training in carbohydrate (CHO)-restricted 
states is potentially regulated through free fatty acid 
(FFA)-mediated signalling and that leucine-rich protein 
elevates muscle protein synthesis, the present study aimed 
to test the hypothesis that leucine-enriched protein feed-
ing enhances circulating leucine concentration but does 
not impair FFA availability or whole body lipid oxidation 
during exercise. Nine males cycled for 2 h at 70 % VO2peak 
when fasted (PLACEBO) or having consumed a whey pro-
tein solution (WHEY) or a leucine-enriched whey protein 
gel (GEL), administered as 22 g 1 h pre-exercise, 11 g/h 
during and 22 g 30 min post-exercise. Total leucine admin-
istration was 14.4 g and 6.3 in GEL and WHEY, respec-
tively. Mean plasma leucine concentrations were elevated 
in GEL (P = 0.001) compared with WHEY and PLA-
CEBO (375 ± 100, 272 ± 51, 146 ± 14 µmol L−1, respec-
tively). No differences (P = 0.153) in plasma FFA (WHEY 
0.53 ± 0.30, GEL 0.45 ± 0.25, PLACEBO 0.65 ± 0.30, 
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“train-low, compete-high” model surmising that athletes 
deliberately complete a portion of their training programme 
with reduced CHO availability so as to augment training 
adaptation but yet always ensure high CHO availability 
prior to and during competition in an attempt to promote 
maximal performance (Burke 2010). The augmented train-
ing response observed with training-low strategies is cur-
rently thought to be regulated via the enhanced activation 
of upstream cell-signalling kinases including both AMPK 
(Yeo et al. 2010) and p38MAPK (Cochran et al. 2010) 
that ultimately converge on the downstream regulation of 
key transcription factors and co-activators such as PGC-
1α (Psilander et al. 2013), p53 (Bartlett et al. 2013) and 
PPARδ (Philp et al. 2013). In this way, training with low 
CHO availability thereby leads to a co-ordinated upregula-
tion of both the nuclear and mitochondrial genomes.
Despite the emergence of the train-low paradigm, its 
practical application in athletic populations is not without 
limitations, most notably a potential reduction in absolute 
training intensities (Yeo et al. 2008) as well as increased 
skeletal muscle protein oxidation and breakdown (Lemon 
and Mullin 1980; Howarth et al. 2010). An obvious solu-
tion to compensate for the latter is to consume high qual-
ity protein in close proximity to the exercise stimulus given 
that protein provision before (Coffey et al. 2011), during 
(Hulston et al. 2011) and after exercise (Breen et al. 2011; 
Howarth et al. 2010) is facilitative of a positive net protein 
balance. In this regard, Pasiakos et al. (2011) also observed 
that enhanced concentration of leucine (3.5 g in 10 g EAA) 
in an essential amino acid mixture consumed during 2 h 
of endurance exercise significantly enhanced post-exer-
cise muscle protein synthesis rates when compared with 
the same total intake of essential amino acids containing 
reduced leucine concentration (1.87 g in 10 g EAA). We 
also observed that consuming protein before, during and 
after acute exercise undertaken in a glycogen-depleted state 
did not impair the activation of the AMPK- PGC-1α path-
way and positively affected molecular regulators of protein 
synthesis (e.g. eEF2 phosphorylation status), thus demon-
strating that high amino acid availability still permits acti-
vation of key cell-signalling cascades thought to regulate 
the training-low response (Taylor et al. 2013). When taken 
together, such data suggest that reduced CHO but high pro-
tein availability (especially leucine-rich protein) may there-
fore be a strategic approach to stimulate training-induced 
adaptations of skeletal muscle.
It is noteworthy, however, that the provision of high pro-
tein availability could hinder additional pathways that may 
be involved in regulation of the training response associated 
with training-low. Indeed, we observed that the elevated 
insulin induced by amino acid ingestion (albeit adminis-
tered as a casein hydrolysate solution) attenuated circulat-
ing free fatty acid (FFA) availability and whole body rates 
of lipid oxidation (Taylor et al. 2013). This effect may be 
problematic given that FFA may also act as signalling inter-
mediates involved in regulating training adaptation in addi-
tion to providing substrate for oxidation (Zbinden-Foncea 
et al. 2013; Philp et al. 2013; Fyffe et al. 2006). Any feed-
ing strategy intended to achieve high protein availability 
(in an attempt to reduce protein breakdown and promote 
protein synthesis) during acute train-low sessions should 
therefore be simultaneously administered with the goal of 
minimising reductions in lipolysis such that FFA-mediated 
cell signalling can still occur.
Accordingly, the aim of the current study was to there-
fore test the hypothesis that leucine-enriched protein feed-
ing enhances circulating leucine availability but does not 
impair FFA availability and lipid oxidation during exercise. 
To this end, we utilised two protein feeding strategies con-
sisting not only a traditional whey protein solution but also 
a novel leucine-enriched protein gel. The use of the lat-
ter is considered particularly advantageous for endurance 
athletes given that gels are a highly practical approach to 
feeding when in locomotion (Pfeiffer et al. 2010, 2012; Lee 
et al. 2014). When taken together, it is hoped that our data 
will be of immediate practical application for those athletes 
who deliberately train in CHO-restricted states in order to 
promote skeletal muscle adaptations that are reflective of 
both mitochondrial and myofibrillar protein synthesis.
Methodology
Subjects
Nine males (age 29 ± 4 years, height 179.7 ± 2.9 cm and 
body mass 79.4 ± 3.3 kg) volunteered to participate in the 
study after providing informed written consent. Subjects 
were recreational and competitive cyclists and tri-athletes 
who trained between 3–7 h per week and had been cycling 
regularly for >1 year. Mean VO2peak and peak power output 
(PPO) for the cohort were 53.0 ± 2.1 ml kg−1 min−1 and 
334 ± 13 W, respectively. None of the subjects had a his-
tory of neurological disease or skeletal muscle abnormality 
and none were under pharmacological intervention during 
the course of the study. Subjects were asked to maintain 
habitual activity levels during the course of the study. The 
study was approved by the Research Ethics Committee of 
Liverpool John Moores University.
Overview of experimental design
In a repeated measures counter-balanced design (using a 
Latin Squares approach) and after having previously com-
pleted an assessment of VO2peak and PPO, subjects reported 
to the laboratory on the morning of the experimental trial 
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(following an overnight fast) on 3 occasions separated 
5–7 days. To determine the sequence of testing (i.e. the 
order of which subjects were tested from 1 to 9), subjects 
were drawn from a random number generator. Subjects 
consumed a standardised diet (5 g kg−1 CHO, 2 g kg−1 
Protein, 1 g kg−1 Fat) and refrained from exercise for the 
48 h prior to all of the testing procedures. With the excep-
tion of the breakfast and pre-bedtime snack (both of which 
were made by the subject themselves and consumed in 
their own home after appropriate dietary instruction), all 
foods were provided in pre-packaged containers and con-
sumed on the university premises in view of author one so 
as to verify compliance. On arrival at the laboratory on the 
morning of the experimental trial, subjects consumed a pro-
tein (in the form of whey or gel) or placebo supplement 1 h 
prior to commencing 2 h of cycling at 60 % PPO (~70 % 
VO2peak), at 30 min intervals during exercise and a final 
dose at 30 min post-exercise. Venous blood samples were 
taken at regular intervals prior to, during and after exercise. 
Measurements of heart rate, substrate oxidation and subjec-
tive ratings of perceived exertion, enjoyment and gastroin-
testinal discomfort were obtained during exercise.
Assessment of maximal oxygen uptake
Peak oxygen consumption (VO2peak) and peak aerobic 
power (PPO) were determined during an incremental 
cycle test performed on an electromagnetically braked 
cycle ergometer (SRM, Julich, Germany). The subjects 
completed a 10-min warm up at 100 W and self-selected 
cadence, before commencing the test which consisted of 
2 min stages with 30 W increments in power until voli-
tional exhaustion. Breath-by-breath measurements were 
obtained throughout exercise using a CPX Ultima series 
online gas analysis system (Medgraphics, Minnesota, US). 
VO2peak was stated as being achieved by the following end-
point criteria: (1) heart rate within 10 beats min−1 of age-
predicted maximum, (2) respiratory exchange ratio >1.1 
and (3) plateau of oxygen consumption despite increased 
workload. Peak aerobic power was taken as the final stage 
completed during the incremental test.
Experimental protocol
Participants arrived at the laboratory in the morning of 
the trial (08:00) having followed a prescribed diet for 
2 days prior and following an overnight fast. After obtain-
ing measures of nude body mass, an indwelling cannula 
(Safety Lock 22G, BD Biosciences, West Sussex UK) was 
inserted into the anticubital vein in the anterior crease of 
the forearm and a resting blood sample drawn. After the 
resting blood sample was taken, the cannula was flushed 
with ~5 ml of sterile saline (Kays Medical supplies. 
Liverpool UK) to keep the cannula patent and sterile, 
this procedure was repeated after each subsequent blood 
draw. Having obtained a resting sample, subjects’ ingested 
ether a non-caloric placebo gel and 500 ml of water (PLA-
CEBO), a leucine-enriched protein gel that is not cur-
rently commercially available (GEL) providing 22 g pro-
tein + 2.4 g leucine (total leucine of 4.8 g) with 500 ml 
of water or 22 g of commercially available whey protein 
(total leucine of 2.1 g; REGO Protein, Science in Sport, 
UK) mixed in 500 ml water (WHEY) and then rested in 
the laboratory for 60 min prior to the start of exercise. The 
nutritional compositions of the protein supplements are 
shown in Table 1. Both the protein gel and placebo gel 
(containing Water, Gellan Gum, Sodium Citrate, Sodium 
Benzoate, Potassium Sorbate, Sodium Chloride, Xanthan 
Gum, Acesulfame K, Ascorbic Acid and Citric Acid) are 
not currently commercially available and were manu-
factured flavour matched in-house in an Informed Sport 
accredited laboratory (Science in Sport, SiS, Nelson, UK). 
On the basis that caffeine can partially restore training 
intensity when in glycogen-depleted states (Lane et al. 
2013) and also that beta-hydroxy beta-methylbutyrate 
(HMB) can reduce muscle protein breakdown (Wilkinson 
et al. 2013), we also chose to fortify our gel with addi-
tional caffeine (100 mg per 22 g of protein) and HMB (1 g 
per 22 g of protein). Blood samples were obtained repeat-
edly at 20 min intervals during the pre-exercise period and 
immediately before exercise commenced. Subjects then 
cycled for 120 min at 60 % PPO (~70 % VO2peak) on a 
fully adjustable electromagnetically braked cycle ergom-
eter (SRM, Julich, Germany). Each subject used their own 
pedals, cleats and shoes during each trial. During exercise, 
feeding of 11 g whey protein with 250 ml water occurred 
at 30 min, 5.5 g at 60 and 90 min in 125 ml water, or a 
volume matched placebo or protein gel and water. Blood 
samples were taken every 20 min during exercise and at 
termination. Substrate oxidation (g min−1) was determined 
during exercise using CPX Ultima series online gas analy-
sis system (Medgraphics, Minnesota, US) using equations 
Table 1  Overview of the nutritional compositions of the gel and 
whey products (protein in both products was from whey isolate 
sources)
gel whey
Total protein (g) 22.0 22.0
Additional leucine (g) 2.4 0.0
Total leucine (g) 4.8 2.1
Total BCAA (g) 7.5 4.9
Total EAA (g) 13.1 9.3
Caffeine (mg) 100.0 0.0
HMB (g) 1.0 0.0
S. G. Impey et al.
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of Jeukendrup and Wallis (2005). Ratings of perceived 
exertion (RPE) (Borg 1970), gastrointestinal discomfort 
(GI) (Pfeiffer et al. 2012) and heart rate (Polar Kempele 
610i, Finland) were recorded every 15 min during exercise. 
Upon completion of exercise, subjects dismounted from 
the ergometer, towel dried and nude mass was recorded. 
Thirty minutes after exercise, subjects consumed a further 
22 g of protein or placebo with 500 ml water in the form 
of whey or gel, and two more blood samples were taken 
at 1 h and 2 h after completion of exercise. Laboratory 
conditions remained constant across all trials (19–21 °C, 
40–50 % humidity). In this way, subjects consumed a total 
of 66 g protein during the protein trials (i.e. 22 g before, 
22 g during and 22 g after exercise) in the form of whey 
protein (total leucine intake of 6.3 g) or a leucine-enriched 
protein gel (total leucine intake of 14.4 g). Upon exercise 
completion, subjects also rated their perceived ratings of 
enjoyment as quantified by the Physical Activity Enjoy-
ment Scale (Kenzierski and DeCarlo 1991).
Blood analysis
Blood samples were collected in vacutainers containing 
K2 EDTA, lithium heparin or serum separation tubes, and 
stored on ice or at room temperature until centrifugation 
at 1,500g for 15 min at 4 °C. Serum and plasma were ali-
quoted and stored at −80 °C until analysis. Plasma glucose, 
lactate, FFA and glycerol were analysed using the Randox 
Daytona spectrophotometer with commercially available 
kits (Randox, Ireland), as per the manufacturer’s instruc-
tions. Serum insulin concentrations were analysed using 
commercially available ELISA (Cobas, Roche Diagnos-
tics, USA) as per the manufacturer’s instructions. Plasma 
amino acids were quantified as their tert-butyldimethylsilyl 
(t-BDMS) derivatives after the addition of suitable internal 
standards by Gas Chromatography-Mass Spectrometry: 
briefly, 200 µl of plasma were deproteinized with 1 ml of 
100 % ethanol, the supernatant dried under nitrogen at 
90 °C, re-dissolved in 500 µl 0.5 M HCl and extracted with 
2 ml ethyl acetate (to remove lipid fraction), and the aque-
ous layer was then dried and derivatized (with 100 µl Ace-
tonitrile and 100 µl MTBSTFA) at 90 °C for 90 min. The 
t-BDMS BCAA derivatives were separated on RTX5-ms 
(15 m × 0.25 id, 0.25 μ film thickness) capillary column, 
initial column temp was 70 °C, then ramped at 12 °C/min 
to 280 °C, injector temperature was 240 °C, Helium carrier 
gas was 1.2 ml/min. Selected ion monitoring of the (M-57) 
fragment was performed for each amino analysed, and the 
area under the peak determined relative to the mass isoto-
pomer of the stable isotopically labelled internal standard 
used for each amino acid, e.g. we monitored m/z 302 for 
Val and Leu and the isotopomer 303 (for 13C Valine) and 
304 (for 1,2 13c2 Leucine).
Statistical analysis
Statistical analysis was conducted using the Statisti-
cal Package for the Social Sciences software programme 
(SPSS, version 18). Changes in physiological and meta-
bolic responses (i.e. physiological variables, amino acids, 
metabolites and substrate oxidation rates) were analysed 
using a two-way repeated measures general linear model 
(GLM) where the within factors were time and condition. 
Additionally, area under the curve (AUC) for metabolites, 
amino acids and insulin was also calculated (using Graph 
Pad Prism, version 6), and differences between conditions 
were assessed using a one-way repeated measures GLM. 
A comparison of subjects’ perceived rating of enjoyment 
during exercise was also analysed according to a one-way 
repeated measures GLM. Where a significant main effect 
was observed, pairwise comparisons were analysed accord-
ing to Bonferoni post hoc tests in order to locate specific 
differences. Statistical significance was set at P < 0.05, 
and all data in text, figures and tables are presented as 
mean ± SEM.
Results
Physiological and perceptual responses during exercise
A comparison of subjects’ physiological and perceptual 
responses during the exercise protocol is shown in Table 2. 
Heart rate (P < 0.01), lipid oxidation (P < 0.01) and RPE 
(P < 0.01) all displayed progressive increases during exer-
cise, whereas CHO oxidation exhibited a significant decline 
(P < 0.01). In contrast, GI discomfort displayed no change 
during exercise (P = 0.14). However, there was no differ-
ence in heart rate (P = 0.84), oxygen uptake (P = 0.67), 
CHO oxidation (P = 0.97), lipid oxidation (P = 0.90), 
RPE (P = 0.11) and GI discomfort (P = 0.19) between the 
PLACEBO, GEL and WHEY trials. Subjects also reported 
a tendency for a higher rating of perceived enjoyment 
(P = 0.073) in the GEL (89 ± 5 AU) versus the WHEY 
(84 ± 5 AU) and PLACEBO (79 ± 5 AU) trials.
Metabolic responses and substrate oxidation 
during exercise
Serum insulin significantly increased in the pre-exercise 
period and also showed significant declines during exercise 
(P < 0.01) in both the WHEY and GEL trials (see Fig. 1). 
Accordingly, insulin displayed significant differences 
between conditions (P < 0.01) where both WHEY (P < 0.01) 
and GEL (P = 0.01) were significantly higher than PLA-
CEBO (see Fig. 1) though no differences were apparent 
between the WHEY and GEL trials (P = 1.0). Total AUC for 
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insulin also displayed differences (P < 0.01) between con-
ditions such that both WHEY and GEL were different from 
PLACEBO (P < 0.01 and P = 0.01, respectively), but no dif-
ferences occurred between WHEY and GEL (P = 1.0)
Exercise induced significant increases in plasma NEFA 
(P < 0.01), glycerol (P < 0.01) and lactate (P < 0.01), 
whereas glucose displayed no significant (P = 0.09) 
change (see Fig. 2a, c, e, f, respectively). Despite signifi-
cant changes in insulin in the protein fed trials, plasma 
NEFA (P = 0.12), glycerol (P = 0.42), glucose (P = 0.19) 
and lactate (P = 0.06) were not different between the 
PLACEBO, WHEY and GEL trials at rest or during exer-
cise. Accordingly, total AUC for NEFA (P = 0.09), glyc-
erol (P = 0.38), glucose (P = 0.1) and lactate (P = 0.07) 
also displayed no differences between treatments.
Plasma amino acid responses
Plasma leucine, BCAAs and EAAs are displayed in Fig. 3a, 
c, e, respectively. Feeding-induced increases in plasma leu-
cine (P < 0.01) were significantly different between con-
ditions (P < 0.01) such that a significant interaction effect 
was observed (P = 0.02). Specifically, plasma leucine was 
significantly greater in GEL versus both WHEY (P < 0.01) 
and PLACEBO (P < 0.01). As such, total AUC for leucine 
was also different between treatments with differences evident 
across all pairwise comparisons (all P < 0.01) (see Fig. 3b).
Similar to leucine, feeding also induced a significant 
increase (both P < 0.01) in plasma BCAAs and EAAs for 
both WHEY and GEL where both a significant effect of 
condition (both P < 0.01) and interaction (P < 0.01 and 
P = 0.04, respectively) were observed. However, pairwise 
comparisons revealed there to be no differences in total 
BCAAs and EAAs between GEL and WHEY (P = 1.0 
and 0.6, respectively) though both were different from 
PLACEBO (P < 0.01). In accordance, although total AUC 
for BCAAs and EAAs displayed significant main effects 
between treatments (both P < 0.01), significant pairwise 
effects (all P < 0.01) were only apparent when comparing 
GEL and WHEY from PLACEBO (see Fig. 3d, f).
Discussion
The aim of the present study was to test the hypothesis 
that leucine-enriched protein feeding enhances circulating 
Table 2  Physiological and 
perceptual responses during 
exercise
* Significant difference from 
30 min, P < 0.05
Time (min)
30 60 90 120
CHO oxidation (g/min)
 Gel 3.14 ± 0.18 2.70 ± 0.23* 2.25 ± 0.15* 1.98 ± 0.15*
 Placebo 3.13 ± 0.19 2.61 ± 0.18* 2.38 ± 0.15* 2.20 ± 0.13*
 Whey 3.13 ± 0.24 2.64 ± 0.22* 2.24 ± 0.17* 1.97 ± 0.18*
Lipid oxidation (g/min)
 Gel 0.12 ± 0.08 0.31 ± 0.11* 0.51 ± 0.06* 0.63 ± 0.05*
 Placebo 0.05 ± 0.07 0.34 ± 0.08* 0.47 ± 0.07* 0.61 ± 0.07*
 Whey 0.11 ± 0.09 0.40 ± 0.08* 0.47 ± 0.07* 0.60 ± 0.07*
HR (b/min)
 Gel 149 ± 4 154 ± 3 158 ± 4* 164 ± 4*
 Placebo 148 ± 3 153 ± 3 157 ± 4* 164 ± 4*
 Whey 152 ± 5 156 ± 3 157 ± 4* 163 ± 3*
VO2 (% max)
 Gel 67 ± 2 68 ± 2 68 ± 2 67 ± 3
 Placebo 67 ± 1 67 ± 1 68 ± 2 70 ± 2
 Whey 66 ± 2 69 ± 1 67 ± 2 68 ± 3
RPE (AU)
 Gel 11 ± 1 13 ± 1* 13 ± 1* 14 ± 1*
 Placebo 12 ± 1 14 ± 1* 15 ± 1* 16 ± 1*
 Whey 12 ± 1 14 ± 1* 14 ± 1* 15 ± 1*
GI (AU)
 Gel 10 ± 1 10 ± 1 10 ± 1 10 ± 1
 Placebo 9 ± 1 10 ± 1 10 ± 1 9 ± 1
 Whey 10 ± 1 11 ± 1 11 ± 1 10 ± 1
S. G. Impey et al.
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leucine availability but does not impair FFA availability and 
lipid oxidation during exercise. To this end, we utilised two 
protein feeding strategies consisting not only a traditional 
whey protein solution but also a novel leucine-enriched 
protein gel. We provide novel data by demonstrating that 
provision of protein (in either of the aforementioned forms) 
before, during and after 2 h of endurance exercise under-
taken in the absence of CHO feeding pre- and during exer-
cise does not impair FFA availability or lipid oxidation. 
Given that the enhanced training response observed when 
training in CHO-restricted states is potentially regulated 
through FFA-mediated signalling and also that leucine-
enriched protein elevates muscle protein synthesis, we 
therefore consider our data to have practical implications 
(i.e. feeding strategies) for those athletes who deliberately 
train in CHO-restricted states in order to enhance skeletal 
muscle adaptations to endurance training.
Despite the apparent advantage to carefully scheduling 
periods of fasted (Van Proeyen et al. 2011) and/or glyco-
gen-depleted endurance training (Yeo et al. 2008; Morton 
et al. 2009), such approaches may be limited in that skel-
etal muscle protein oxidation and breakdown are increased 
(Lemon and Mullin 1980; Howarth et al. 2010), and hence 
net protein balance becomes negative if amino acids are 
also not ingested (Hulston et al. 2011). If performed chron-
ically (especially in the presence of reduced daily caloric 
intake), this approach could therefore lead to a loss of skel-
etal muscle mass (Cabone et al. 2013; Mettler et al. 2010; 
Pasiakos et al. 2013) and potentially a de-training effect 
(Breen et al. 2011). To this end, we recently demonstrated 
that consuming a casein hydrolysate solution before, dur-
ing and after glycogen-depleted exercise does not impair 
activation of mitochondrial related signalling pathways 
(e.g. AMPK- PGC-1α) as well as positively affecting 
molecular regulators of protein synthesis (e.g. eEF2 phos-
phorylation status) (Taylor et al. 2013). As such, many elite 
endurance cyclists now perform prolonged morning rides 
in CHO-restricted states but with protein-rich breakfasts 
and additional protein during exercise (typically in the form 
of whey/casein drinks) in a deliberate attempt to promote 
oxidative adaptations of skeletal muscle (Walsh 2014).
In terms of modulating protein synthesis, however, cur-
rent evidence also suggests that both rapidly digestible but 
leucine-rich proteins are the optimal protein source. For 
example, Pasiakos et al. (2011) observed that enhanced 
concentration of leucine (3.5 g in 10 g EAA) in an essen-
tial amino acid mixture consumed during 2 h of endur-
ance exercise significantly enhanced post-exercise mus-
cle protein synthesis rates when compared with the same 
total intake of essential amino acids but containing reduced 
leucine concentration (1.87 g in 10 g EAA). Furthermore, 
Churchward-Venne et al. (2014) demonstrated compara-
ble post-exercise myofibrillar synthesis rates (albeit from 
a resistance exercise stimulus) from mixed macronutrient 
drinks containing 25 g whey versus a bolus of 6.25 g whey 
supplemented with 5 g leucine. Such observations therefore 
formed the underlying rationale for the present study in 
terms of studying not only whey protein (naturally high in 
leucine) but also a novel leucine-enriched protein gel. Total 
leucine administration during the data collection period 
(i.e. 5 h) was 14.4 and 6.3 g in whey and gel, respectively. 
Accordingly, mean plasma leucine levels were higher in 
gel versus whey, and in both feeding strategies, plasma leu-
cinemia increased to levels that would be expected to pro-
mote post-exercise muscle protein synthesis (Breen et al. 
2011; Pasiakos et al. 2011). Unfortunately, direct estimates 
of muscle protein synthesis (and related molecular regula-
tors) were neither obtained in the present study nor did we 
quantify rates of leucine oxidation. Future studies would 
therefore benefit from direct measures of both mixed mus-
cle protein synthesis (and in sub-cellular fractions) as well 
as leucine oxidation, both achieved via the inclusion of 
muscle biopsies and stable isotope methodology.
Although we readily acknowledge that the total leucine 
delivery in both trials may appear as excessive in terms of 
that required to facilitate maximal protein synthesis as well 
as likely resulting in elevated leucine oxidation (Bowtell 
et al. 1998), we deliberately chose this dosing strategy for 
a number of practical reasons. Firstly, given that exercis-
ing in CHO-restricted states augments leucine oxidation 
(Lemon and Mullin 1980; Wagenmakers et al. 1991; How-
arth et al. 2010), it was our deliberate aim to administer 
higher exogenous leucine so as to deliver both substrate to 
promote muscle protein synthesis (Breen et al. 2011; Pasia-
kos et al. 2011; Churchward-Venne et al. 2014) but yet also 
Fig. 1  Serum insulin concentrations before, during and after exer-
cise. Total area under the curve for insulin is also shown inset. 
Shaded area represents the exercise bout. Downward arrows denote 
timing of treatment ingestion. Asterisk denotes significant difference 
from baseline values, i.e. minute 0, P < 0.05. Letter a denotes signifi-
cant difference from PLACEBO, P < 0.05
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compensate for the higher levels of endogenous leucine 
oxidation (Lemon and Mullin 1980; Wagenmakers et al. 
1991; Howarth et al. 2010). Second, unpublished obser-
vations by the corresponding author on elite professional 
cyclists indicated that this is the type of protein feeding 
strategy actually adopted during morning training rides that 
are deliberately undertaken in the absence of CHO intake 
before and during exercise. As such, our initial aim was to 
replicate these “real world” strategies and determine if such 
doses of protein actually impairs FFA availability and lipid 
oxidation. Finally, given that many elite cyclists are poten-
tially in daily energy deficits (Vogt et al. 2005) with low 
Fig. 2  Plasma (a) NEFA, (c) 
glycerol, (e) glucose and (g) 
lactate before, during and after 
exercise. Shaded area represents 
the exercise bout. Downward 
arrows denote timing of treat-
ment ingestion. Total area under 
the curve (AUC) for NEFA 
(b), glycerol (d), glucose (f) 
and lactate (h) is also shown in 
the right-hand panels. Asterisk 
denotes significant difference 
from baseline values, i.e. minute 
0, P < 0.05
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energy availability (Loucks et al. 2011), and also that 2–3× 
RDA for daily protein is required to maintain lean mass 
during energy restriction (Pasiakos et al. 2013), we there-
fore considered this feeding strategy to be in accordance 
with daily protein intakes for both quantity and frequency 
(Areta et al. 2013). For example, over the 5 h data collec-
tion period (i.e. 8 am to 1 pm), the present subjects (ranging 
from 67 to 86 kg) consumed 66 g protein and hence for the 
daily target to be achieved (i.e. approximately 160–200 g), 
our approach is therefore in accordance with a feeding 
strategy where subsequent 30 g doses could be consumed 
at 3 h intervals (e.g. 2, 5, 8 and 11 pm if required).
In terms of modulating the train-low response, the 
important aspect of the present paper is that neither the 
whey protein solution nor the leucine-enriched protein 
gel attenuated circulating FFA availability or whole body 
rates of lipid oxidation during exercise, despite elevated 
serum insulin levels in the pre-exercise period. This find-
ing is especially relevant considering that the enhanced 
training response observed when training with low CHO 
availability (particularly the elevated capacity for lipid oxi-
dation during customary exercise) is likely regulated, in 
part, through FFA-mediated signalling. Indeed, the exer-
cise-induced increase in p38MAPK activity is blunted by 
pharmacological reduction of circulating FFA availability 
(Zbinden-Foncea et al. 2013). Furthermore, exercise under-
taken in a glycogen-depleted state increases PPARδ bind-
ing to the CPT1 promoter (Philp et al. 2013), the latter 
considered as a rate limiting enzyme for long chain fatty 
acid oxidation. The observation of no apparent reduction in 
lipolysis with protein feeding in the present study disagrees 
with previous observations from our laboratory where we 
Fig. 3  Plasma (a) leucine, (c) 
BCAAs and (e) EAAs before, 
during and after exercise. 
Shaded area represents the exer-
cise bout. Downward arrows 
denote timing of treatment 
ingestion. Asterisk denotes sig-
nificant difference from baseline 
values, i.e. minute 0, P < 0.05. 
Total area under the curve 
(AUC) for leucine (b), BCAAs 
(d) and EAAs (f) is also shown 
in the right-hand panels. Letter 
a denotes significant difference 
from PLACEBO, P < 0.05. 
Letter b denotes significant dif-
ference from whey, P < 0.05
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demonstrated that a casein hydrolysate solution (adminis-
tered as 20 g 45 min pre-exercise, 10 g during exercise and 
20 g post-exercise) attenuated plasma FFA availability and 
whole body rates of lipid oxidation during exercise. Such 
discrepancies may be due in part to differences in timing 
of pre-exercise feeding (i.e. 60 versus 45 min before exer-
cise) as well as type of protein consumed (i.e. casein hydro-
lysate versus predominantly whey isolate proteins). The 
latter point is particularly relevant given that hydrolysate 
proteins induce greater insulin responses compared with 
isolated protein sources (Tang et al. 2009; Pennings et al. 
2011). As such, the effects of protein ingestion on meta-
bolic responses during exercise are likely dependent upon 
the interplay of a number of important factors including 
type and timing of protein ingestion. Such factors should 
therefore be taken into consideration when designing real 
world feeding strategies.
To achieve our delivery for the leucine-enriched pro-
tein trial, we chose to develop a novel protein-based gel. 
Indeed, considering that leucine is often not readily solu-
ble in water, we reasoned that a gel format provided a 
more convenient approach for which to deliver a leucine-
enriched protein source. Moreover, gels are a highly practi-
cal approach to carrying fuel and feeding whilst in loco-
motion as opposed to conventional approaches of fluid 
delivery (Pfeiffer et al. 2010; Lee et al. 2014). Accord-
ingly, gels are a highly utilised form of supplement by 
endurance athletes (Pfeiffer et al. 2012). On the basis that 
caffeine can partially restore training intensity when in 
glycogen-depleted states (Lane et al. 2013) and also that 
beta-hydroxy beta-methylbutyrate (HMB) can reduce mus-
cle protein breakdown (Wilkinson et al. 2013), we also 
chose to fortify our gel with additional caffeine (100 mg 
per 22 g of protein) and HMB (1 g per 22 g of protein). 
Although we did not measure parameters related to these 
products given that our exercise protocol was clamped (i.e. 
2 h fixed intensity of 70 % VO2peak) and no indices of pro-
tein breakdown were obtained, our observations of no dif-
ferences in gastrointestinal discomfort between trials sup-
port the notion that multiple ingredients in the gel format 
were well tolerated. Interestingly, subjects’ ratings of per-
ceived enjoyment (as quantified by the Physical Activity 
Enjoyment Scale) also tended to be higher in gel (90 ± 5) 
versus both whey (84 ± 5) and PLACEBO (79 ± 5). Given 
that this scale takes into account subjective measurements 
of mood status related to vigour and arousal, this observa-
tion maybe related to the higher plasma concentrations of 
leucine observed in the gel trial and is accordance with the 
hypothesis that elevated BCAAs (especially in conditions 
of low CHO availability) may alleviate symptoms of cen-
tral fatigue (Blomstrand et al. 2005; Blomstrand 2006).
In summary, we provide novel data by demonstrating 
that neither a whey protein solution nor a leucine-enriched 
protein gel impairs circulating FFA availability or rates of 
whole body lipid oxidation during 2 h of endurance exer-
cise undertaken in a CHO-restricted state. Given that the 
augmented training response observed when training with 
reduced CHO availability (i.e. absence of CHO provision 
before/during exercise and/or glycogen-depleted condi-
tions) is potentially regulated through FFA-mediated sig-
nalling and also that leucine-rich protein elevates muscle 
protein synthesis, we consider our data to have practical 
implications for those athletes who deliberately train in 
CHO-restricted states in order to enhance skeletal mus-
cle adaptations to endurance training (as reflective of both 
mitochondrial and myofibrillar protein synthesis). Further 
studies are now required to examine both the acute (e.g. cell 
signalling, gene expression responses and direct measures 
of protein turnover) and chronic effects (e.g. mitochondrial 
adaptations) of reduced CHO but high protein availability 
on skeletal muscle adaptation to endurance training as well 
as potential impact on measures of exercise performance.
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